Tag Archives: monoclonal antibody cancer drug

The National Health Service in England is preparing to introduce a new, streamlined cancer treatment in the form of a single injection that can target up to 15 different types of cancer. The therapy, based on the drug nivolumab, marks a major shift in how immunotherapy is administered, replacing conventional hour-long intravenous infusions with a subcutaneous jab that takes approximately …

Read More »